Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus Paper: Ataxic Gait.
Cabaraux P, Agrawal SK, Cai H, Calabro RS, Casali C, Damm L, Doss S, Habas C, Horn AKE, Ilg W, Louis ED, Mitoma H, Monaco V, Petracca M, Ranavolo A, Rao AK, Ruggieri S, Schirinzi T, Serrao M, Summa S, Strupp M, Surgent O, Synofzik M, Tao S, Terasi H, Torres-Russotto D, Travers B, Roper JA, Manto M. Cabaraux P, et al. Among authors: ruggieri s. Cerebellum. 2023 Jun;22(3):394-430. doi: 10.1007/s12311-022-01373-9. Epub 2022 Apr 12. Cerebellum. 2023. PMID: 35414041
Correction to: Consensus Paper: Ataxic Gait.
Cabaraux P, Agrawal SK, Cai H, Calabro RS, Casali C, Damm L, Doss S, Habas C, Horn AKE, Ilg W, Louis ED, Mitoma H, Monaco V, Petracca M, Ranavolo A, Rao AK, Ruggieri S, Schirinzi T, Serrao M, Summa S, Strupp M, Surgent O, Synofzik M, Tao S, Terasi H, Torres-Russotto D, Travers B, Roper JA, Manto M. Cabaraux P, et al. Among authors: ruggieri s. Cerebellum. 2023 Jun;22(3):431-432. doi: 10.1007/s12311-022-01413-4. Cerebellum. 2023. PMID: 35536510 No abstract available.
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience.
Ruggieri S, Ianniello A, Copetti M, Altieri M, Buscarinu MC, Centonze D, Cortese A, De Giglio L, Fantozzi R, Gasperini C, Grimaldi LME, Landi D, Marfia GA, Mirabella M, Nistri R, Nociti V, Oddo O, Romano S, Salemi G, Tortorella C, Pozzilli C, Petracca M. Ruggieri S, et al. Neurotherapeutics. 2024 Feb 26;21(3):e00338. doi: 10.1016/j.neurot.2024.e00338. Online ahead of print. Neurotherapeutics. 2024. PMID: 38413275 Free PMC article.
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
Petracca M, Ruggieri S, Barbuti E, Ianniello A, Fantozzi R, Maniscalco GT, Andreone V, Landi D, Marfia GA, Di Gregorio M, Iodice R, Sinisi L, Maida E, Missione R, Coppola C, Bonavita S, Borriello G, Centonze D, Lus G, Pozzilli C, Signoriello E. Petracca M, et al. Among authors: ruggieri s. Neurol Ther. 2022 Sep;11(3):1193-1208. doi: 10.1007/s40120-022-00364-6. Epub 2022 Jun 2. Neurol Ther. 2022. PMID: 35653061 Free PMC article.
548 results